Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism.

Xiaoqing Huang,Qiongyun Chen,Yanyun Fan,Renzhi Yang,Guoyu Gong,Changsheng Yan,Yang Song,Bangzhou Zhang,Shengyan Xi,Yuanpeng Huang,Hongzhi Xu

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie（2023）

引用 3|浏览10

暂无评分

摘要

FOSs alleviated the pathological phenotype of NAFLD via remodeling of the gut microbiota composition and decreasing hepatic lipid metabolism, suggesting that FOSs as functional dietary supplements can potentially reduce the risk of NAFLD.

查看译文

关键词

Fructooligosaccharides,Functional dietary supplement,Intestinal microbiota,Lipid metabolism,Nonalcoholic fatty liver disease

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要